MariMed Inc. ( MRMD) - Stock Earnings
MRMD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
MRMD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.3 million USD | 38.8 million USD |
| 2023Q4 | -10.2 million USD | 38.9 million USD |
| 2024Q1 | -1.3 million USD | 37.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MRMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 7.2 million USD | 121.5 million USD |
| 2022 | 13.5 million USD | 134.0 million USD |
| 2023 | -16.0 million USD | 148.6 million USD |
| 2026 Est. | — | — |
MRMD
Price: $0.07
Earnings Per Share: -0.05 USD
P/E Ratio: -1.68
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 278400
Market Capitalization: 27.5 million